$3.5B Auspex-Teva Merger Challenge Axed By Chancery
A Delaware Chancery Court threw out a complaint from shareholders challenging the $3.5 billion Auspex Pharmaceuticals Inc. all-cash merger with Teva Pharmaceuticals Industries Ltd., finding Thursday that the investors failed to...To view the full article, register now.
Already a subscriber? Click here to view full article